{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:05:36Z","timestamp":1777871136788,"version":"3.51.4"},"reference-count":5,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jaad.2025.02.056","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T10:57:53Z","timestamp":1740221873000},"page":"1456-1457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Despite progesterone receptor affinity, spironolactone is not associated with meningioma development: A population-based cohort study"],"prefix":"10.1016","volume":"92","author":[{"given":"Aubrey","family":"Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Chi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina Yi","family":"Jin Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryanne M.","family":"Senna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jaad.2025.02.056_bib1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11060-022-04187-1","article-title":"Hormone therapies in meningioma-where are we?","volume":"161","author":"Miyagishima","year":"2023","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jaad.2025.02.056_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078078","article-title":"Use of progestogens and the risk of intracranial meningioma: national case-control study","volume":"384","author":"Roland","year":"2024","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.jaad.2025.02.056_bib3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jocn.2013.06.008","article-title":"An audit of immunohistochemical marker patterns in meningioma","volume":"21","author":"Baxter","year":"2014","journal-title":"J Clin Neurosci"},{"issue":"2","key":"10.1016\/j.jaad.2025.02.056_bib4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.canep.2011.08.003","article-title":"Hormonal therapies and meningioma: is there a link?","volume":"36","author":"Cea-Soriano","year":"2012","journal-title":"Cancer Epidemiol"},{"issue":"5","key":"10.1016\/j.jaad.2025.02.056_bib5","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1210\/en.2005-1318","article-title":"Protective effect of spironolactone on endothelial cell apoptosis","volume":"147","author":"Williams","year":"2006","journal-title":"Endocrinology"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225003494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225003494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T17:02:30Z","timestamp":1777568550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225003494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0190962225003494"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.02.056","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Despite progesterone receptor affinity, spironolactone is not associated with meningioma development: A population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.02.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}